## SBAC: SBA Communications Corporation - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 1.1% below STRENGTH zone (3.0-6.0%); PEG 1.88 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($185.09)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. American Tower (AMT): Valuation Check After Barclays Downgrade Versus Strong Q3 Earnings and Upgraded Guidance**
- Source: Simply Wall Street | 20251210T205359 | Somewhat-Bullish | Relevance: 62%
-  American Tower (AMT) recently faced a downgrade from Barclays due to concerns about 2026 growth risks and EchoStar rent exposure, despite a strong Q3 earnings report and upgraded guidance. The stock, currently trading at $179.55, appears undervalued based on its 28.6x P/E ratio compared to peers and an estimated fair P/E of 32.9x, and even more so according to Simply Wall St's DCF model with a fair value estimate of $263.01. Investors are weighing the downgrade's implications against the company's solid earnings performanc and dividend payouts.

**2. How Is Iron Mountainâ€™s Stock Performance Compared to Other Real Estate Stocks?**
- Source: Markets Financial Content | 20251210T050100 | Neutral | Relevance: 61%
-  Iron Mountain (IRM) has underperformed the Real Estate Select Sector SPDR Fund (XLRE) and a rival, SBA Communications (SBAC), over several periods, with its stock dipping significantly from its 52-week high. A short-seller's report further pressured the stock, raising concerns about valuation and growth strategy. Despite this, analysts maintain a "Moderate Buy" rating with a considerable upside potential.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | Barclays | $212 | $219 | -3% |
| 2025-11-17 | Barclays | $219 | $226 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | Barclays | main | Overweight |
| 2025-11-17 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 9 / 1 |

**Top Holders:**
- Vanguard Group Inc: 17.1% (+2.3%)
- Blackrock Inc.: 9.4% (+1.8%)
- JPMORGAN CHASE & CO: 9.3% (+79.6%)
- Dodge & Cox Inc.: 9.1% (+12.3%)
- State Street Corpora: 4.5% (+3.0%)

### Key Risks

1. Long-term trend broken: trading 10.2% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +3.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.88 elevated, pricing in significant growth expectations. Quality metrics strong (margin 31%). Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (9 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.5B |
| Beta | 0.86 |
| 52W Range | $185.13 - $245.16 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.88 |
| Forward P/E | 21.9 |
| Current P/E | 18.9 |
| YoY Growth | -13.4% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -2.5% to 1.1% (+3.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.9pp (needs >3.0% for momentum thesis). MRS_5 at 1.3% confirms short-term momentum alignment. Outperforming sector by 3.5pp, stock-specific strength. Below SMA200 (0.90x), long-term trend not supportive. RSI neutral at 50.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.12% (CS: 50) | Neutral |
| RSI_14 | 50.3 | Neutral |
| MACD Histogram | -0.05 | Bearish |
| vs SMA20 | 1.001x | Above |
| vs SMA50 | 0.996x | Below |
| vs SMA200 | 0.898x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $192.83
- **Stop Loss:** $185.09 (4.0% risk)
- **Target:** $200.57 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 178
- **Position Value:** $34,323.74
- **Portfolio %:** 34.32%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-23 (Est: $3.85)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.16 | $2.20 | +1.8% |
| 2025Q2 | $2.26 | $2.09 | -7.5% |
| 2025Q1 | $2.32 | $1.77 | -23.6% |
| 2024Q4 | $2.31 | $2.33 | +0.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*